The Glutamine Global industry size is estimated to reach USD 140.2 million in 2024 and further expand at a CAGR of 3.6% during the forecast period. Global sales are predicted to soar steadily, totaling USD 199 million by 2034.
Consumers mostly prefer powder form owing to high versatility, cost-effectiveness, and extended shelf life. The target segment accounted for a value share of 58% in 2023 and is poised to register a CAGR of 3.2% during the assessment period.
From improving immunity to promoting gut health, glutamine demand is growing steadily across the world. The product is being increasingly incorporated into food and beverage products, dietary supplements, and nutraceuticals due to potential health benefits.
Growing awareness of the importance of fitness and nutrition, especially across developing nations, is set to create demand for glutamine supplements. Health-conscious consumers consume many supplements to improve immunity and bodily processes.
The amino acid promotes muscle recovery and enhances performance. As a result, the product is witnessing high popularity and demand among fitness enthusiasts and athletes globally.
Robust growth of the pharmaceutical sector is expected to uplift product demand. The target amino acid has shown promising results in treating conditions like obesity, sickle cell disease, ulcers, and glutamine synthetase deficiency. This is feeling its adoption in pharmaceutical formulations.
Growing popularity of personalized nutrition, especially in developed nations, is set to fuel sales growth. This amino acid is often used in personalized supplement plans owing to the product’s various potential health benefits.
Leading players are innovating to make formulations more palatable, bioavailable, and convenient. This will likely play a key role in shaping the growth trajectory of the industry during the assessment period.
Advances in fermentation and biotechnology are allowing companies to improve production efficiency and reduce costs. This will make the product more accessible to end-use industries like food and beverage and dietary supplements.
Attributes | Description |
---|---|
Estimated Global Glutamine Market Size (2024E) | USD 140.2 million |
Projected Global Glutamine Market Value (2034F) | USD 199 million |
Value-based CAGR (2024 to 2034) | 3.6% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Rising Health Consciousness Boosting Growth of Glutamine Market
In the contemporary world, people are becoming more health-conscious, leading to increasing demand for glutamine supplementation. The product’s potential benefits for supporting gut health, immune function, and muscle repair are increasing its popularity among health-conscious consumers and fitness enthusiasts.
High adoption of dietary supplements and nutraceuticals is also facilitating industry development. Similarly, growing prevalence of chronic diseases like digestive disorders, cancer, and AIDS will likely increase product demand in healthcare.
Escalating Importance in Pharmaceuticals Fueling Product Demand
Glutamine is being widely used in pharmaceutical applications, including enteral and parenteral nutrition formulations. This amino acid is a significant nitrogen source for the body, essential for the production of nucleotides, proteins, and other molecules.
Supplements infused with the amino acid have the potential to manage many symptoms associated with chronic diseases and improve health outcomes. Thus, as the cases of chronic diseases continue to increase, so will popularity and adoption of the target product.
The product’s ability to enhance immune function, intestinal health, and wound healing is also encouraging adoption in several medications. Research has shown that glutamine supplementation can be beneficial for people who are malnourished, critically ill, or have undergone surgery.
Rising Plant-based Product Trend Widening Industry Scope
Growing trends like veganism and escalating popularity of plant-based products are having a positive influence on the market. Due to these trends, there is a growing preference and demand for products derived from plant sources.
Increasing concerns about animal welfare and sustainability are also directing manufacturers and consumers towards plant-based glutamine. Several people are also inclined towards using plant-based proteins.
In the future, it is expected that more and more companies will look to create products from plant sources to cater to specific dietary preferences of vegans and other consumers. This will likely benefit the target sector.
Availability from Natural Sources and Potential Side Effects Limiting Growth
There is no doubt that glutamine offers several health benefits. However, despite growing popularity of this product, the market is facing certain limitations that might limit growth. These include potential side effects and availability from natural sources.
Excessive consumption of supplements, including the target amino acid, can cause side effects like diarrhea, stomach cramps, and nausea. This can demotivate consumers, particularly those with sensitive digestive systems, to refrain from using supplements.
Another factor limiting industry growth is the availability of alternatives or natural sources. Many people prefer to consume protein-rich foods like meat, dairy, and fish rather than taking supplements. This might negatively impact the target sector.
Global sales recorded a CAGR of 5.2% between 2019 and 2023. This high growth was fueled by increased interest in gut health and high consumption of immunity-enhancing supplements globally.
During the historical period, there was a growing interest in gut health. This generated significant demand for glutamine owing to the product’s ability to maintain integrity of intestinal lining, prevent leaky gut syndrome, and enhance gut health.
The COVID-19 pandemic also created high demand for immunity-boosting supplements across the world. This further increased product sales and boosted industry growth.
Looking ahead, the future forecast for glutamine industry looks optimistic despite a 1.6% reduction in CAGR compared to the historical growth rate. This growth is set to be fueled by increasing product usage in applications like dietary supplements, pharmaceuticals, sports nutrition, and clinical nutrition.
Another prominent factor expected to create growth opportunities for glutamine manufacturers is the increasing incidence of chronic diseases like cancer and digestive disorders. This amino acid plays a key role in managing various chronic diseases and reducing symptoms.
The product’s growing popularity as a medical food is anticipated to boost sales growth during the assessment period. Healthcare professionals often prescribe the product to patients who need supplementary glutamine due to metabolic demands.
The section below depicts glutamine market forecast across various countries. South Korea and Japan are anticipated to witness significant growth, registering CAGRs of 6% and 5.2%, respectively, through 2034.
The regional analysis of glutamine market is also given to determine key pockets for companies closely. An overview of glutamine market in Asia Pacific indicates Korea to witness robust growth.
Countries | CAGR 2024 to 2034 |
---|---|
United States | 3.9% |
China | 4.2% |
United Kingdom | 4.8% |
Japan | 5.2% |
South Korea | 6% |
The United States remains a highly remunerative pocket for manufacturers. This is attributable to a confluence of factors, including booming pharmaceutical and fitness sectors, high chronic disease incidence, and surging demand for fortified products.
Sales of glutamine in the United States are projected to soar at a 3.9% CAGR during the assessment period. By 2034, total revenue in the nation will likely reach USD 35.4 million.
Amid growing health consciousness, there is a significant upsurge in fitness enthusiasts, gyms, and athletic events in the United States. This, in turn, is anticipated to propel demand for glutamine supplements that help in muscle recovery and performance improvement.
The United States is also home to several leading manufacturers. Developing novel formulations with better bioavailability and palatability is becoming a go-to strategy for United States-based companies.
The United Kingdom is poised to exhibit a CAGR of 4.8% during the assessment period, with sales totaling USD 8.1 million by 2034. Rising health and wellness trends and growing nutritional supplement industry.
The health and fitness movement in European nations, especially the United Kingdom, is gaining ground. This is expected to propel demand during the assessment period.
Consumers in the nation are increasingly opting for supplements to support their well-being. This is leading to expansion of the supplement sector, which consequently propels product demand.
There is also a surge in the geriatric population across the United Kingdom. This will likely uplift product demand in the nation due to its potential to support wellness as people age.
China is anticipated to register a CAGR of 4.2% during the assessment period, with sales totaling USD 31.2 million by 2034. This can be attributed to factors like increasing fitness culture and surging demand for sports nutrition products.
The fitness culture in China is gaining ground, with millennials and fitness enthusiasts seeking performance-enhancing supplements. This will likely create growth opportunities for market players in the country through 2034.
The section below sheds some light on key segments. The detailed glutamine market segmentation analysis can help companies invest in popular products and forms to boost revenues and stay ahead.
Currently, the L-type segment dominates the global industry, accounting for a value share of 63% in 2023. The latest analysis of glutamine industry estimates powder segment to record a CAGR of 3.2% through 2034.
Segment | L-glutamine (Type) |
---|---|
Value Share (2023) | 63% |
L-glutamine is set to remain at the forefront in the market owing to potential health benefits and wide applications. The target segment accounted for a revenue share of 63% in 2024 and is slated to experience a CAGR of 3.4% through 2034.
L type is widely known for several health benefits like immune function, gut health promotion, and muscle recovery. As a result, demand for this product continues to upsurge amid growing consumer focus on health and wellness.
People often consume L form to improve immunity and heal wounds. Increasing usage of the product in applications like sports nutrition supplements, nutraceuticals, and functional foods is another key factor behind the segment’s dominance and growth.
The optimistic pharma-grade L-glutamine market scope, especially across nations like the United States, will likely boost segment growth. The product is widely used in several medical formulations.
Segment | Powder (Form) |
---|---|
Value Share (2023) | 58% |
Currently, powdered segment leads the market. The segment accounted for a prominent share of 58% in 2023 and is forecast to advance at 3.2% CAGR during the next decade. This can be attributed to high adoption of powdered form due to advantages like versatility, extended shelf life, and cost-effectiveness.
Glutamine powder can be easily mixed with water, smoothies, and protein shakes. This versatility and convenience of powdered form make the product popular among consumers globally.
Powdered products are also inexpensive than tablets and capsules. Similarly, powder’s extended shelf life is encouraging its adoption across diverse sectors, including dietary supplements, food and beverages, and animal nutrition.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
With growing demand for protein supplements, the competitive landscape in glutamine market is becoming fiercer. To survive and succeed in this industry, companies are implementing various strategies.
Leading players, such as Kyowa Hakko Bio Co. Ltd., Amino GmbH, and NutraBio Labs, are focusing on creating new formulations and delivery methods targeting specific consumer needs. For instance, new products are being created for athletes and clinical nutrition.
Companies are also directing investments in research to back the claims of health benefits of the target amino acid. Similarly, market leaders are emphasizing quality and transparency to build consumer trust.
Several companies are adopting inorganic strategies like acquisitions, partnerships, mergers, and distribution agreements to stay ahead of the competition. Targeted campaigns and other marketing tactics are becoming prevalent as players look to increase customer base.
Industry Updates
In terms of type, the industry has been categorized into L and D-glutamine.
The product comes in capsules and tablets, powder, and liquid forms.
Based on source, the report is divided into plant-based, animal-based, and fermentation-based.
In terms of applications, the report is segmented into dietary supplements, pharmaceuticals, sports nutrition, clinical nutrition, food and beverages, animal nutrition, and others.
Industry analysis has been carried out in key countries of North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.
The global industry value is set to total USD 140.2 million in 2024.
The target market is forecast to record a CAGR of 3.6% CAGR through 2034.
By 2034, the global industry value is projected to total USD 199 million.
Powder.
Kyowa Hakko Bio Co. Ltd., Ajinomoto Co. Inc., and Evonik Industries AG.
Around 3700 rupees in India.
Transparent Labs BCAA, Now Foods, and NutraBio Labs, among others.
Explore Food and Beverage Insights
View Reports